Sign in

CIK 0001579428 · Large accelerated filer

Axsome Therapeutics, Inc.

Sign in to watch
Ticker
AXSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
454241907
Phone
(212) 332-3241
Business address
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
  1. 4 Planned sale Chief Operating Officer sold 10,000 shares at $208.65 ($2,086,500)
  2. 4 Planned sale Chief Executive Officer sold 49,664 shares at an average $212.19 ($10,538,305)
  3. 4 Planned sale Chief Executive Officer sold 49,666 shares at $240.25 ($11,932,257)
  4. 4 Planned sale Director sold 572 shares at an average $247.65 ($141,656)
  5. 4 Option exercise Director acquired 1,429 shares (option exercise)
  6. 4 Option exercise Director acquired 1,429 shares (option exercise)
  7. 4 Planned sale Director sold 600 shares at an average $241.70 ($145,017)
  8. 4 Planned sale Director sold 643 shares at $249.00 ($160,107)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Planned sale Chief Executive Officer sold 49,670 shares at $241.01 ($11,970,967)
  12. 4 Planned sale Chief Financial Officer sold 33,000 shares at $240.09 ($7,922,970)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Planned sale Director sold 17,537 shares at an average $229.20 ($4,019,470)
  16. 4 Planned sale Chief Operating Officer sold 4,750 shares at an average $227.95 ($1,082,771)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Planned sale Chief Commercial Officer sold 7,500 shares at $182.42 ($1,368,150)
  20. 4 Derivatives Options or other derivatives

Page 1 of 11 · 211 filings